abatacept
bms
['abatacept']
castrejon et al. cancer risk with b/tsdmard in biobadaser. again not looking great for abatacept, rate ratio vs tnfi 2.2 (1.4-3.2). age-adjusted hr 1.6 (1.0-2.6) #acr22 abstr#1752 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC